menu
    • menu

    Company profile for Lighthouse Pharmaceuticals

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lighthouse Pharmaceuticals is a clinical stage private biopharmaceutical company pioneering precision medicine approaches to major unmet medical needs based on expertise in small molecule protease inhibition. Lighthouse’s lead program, LHP588, beginning Phase 2 clinical studies, targets a specific, infectious pathogen, Porphyromonas gingivalis, which is associated with chronic degenerative and inflammatory disorders includin...
    Lighthouse Pharmaceuticals is a clinical stage private biopharmaceutical company pioneering precision medicine approaches to major unmet medical needs based on expertise in small molecule protease inhibition. Lighthouse’s lead program, LHP588, beginning Phase 2 clinical studies, targets a specific, infectious pathogen, Porphyromonas gingivalis, which is associated with chronic degenerative and inflammatory disorders including dementia, periodontal disease, atherosclerosis, and orodigestive cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lighthouse PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Francisco, California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lighthousepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lighthouse Pharma Presents Phase 2 SPRING Trial of LHP588 at CTAD
    Lighthouse Pharma Presents Phase 2 SPRING Trial of LHP588 at CTAD

    26 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-to-present-phase-2-spring-trial-of-lhp588-a-next-generation-gingipain-inhibitor-for-the-treatment-of-p-gingivalis-positive-alzheimers-disease-at-ctad-2025-302626220.html

    PR NEWSWIRE
    26 Nov 2025
    Share Share
    Phibro, Lighthouse Partner For Dog Periodontal Health Asset
    Phibro, Lighthouse Partner For Dog Periodontal Health Asset

    09 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251009727133/en/Phibro-Animal-Health-Corporation-Announces-Licensing-Agreement-with-Lighthouse-Pharmaceuticals-Inc.-for-Innovative-Periodontal-Health-Asset-for-Dogs

    BUSINESSWIRE
    09 Oct 2025
    Share Share
    Lighthouse Gets $49.2M NIA Grant for Alzheimer's Study of LHP588
    Lighthouse Gets $49.2M NIA Grant for Alzheimer's Study of LHP588

    23 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-receives-49-2-million-grant-from-nia-to-advance-phase-2-study-of-lhp588-for-p-gingivalis-positive-alzheimers-disease-302536299.html

    PR NEWSWIRE
    23 Aug 2025
    Share Share
    Lighthouse Announces FDA Approval To Proceed With Phase 2 Spring Trial Of LHP588
    Lighthouse Announces FDA Approval To Proceed With Phase 2 Spring Trial Of LHP588

    16 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-announces-fda-approval-to-proceed-with-phase-2-spring-trial-of-lhp588-a-next-generation-treatment-for-p-gingivalis-positive-alzheimers-disease-301990086.html

    PR NEWSWIRE
    16 Nov 2023
    Share Share
    Lighthouse Pharmaceuticals Announces Presentation at the 2023 ASCP
    Lighthouse Pharmaceuticals Announces Presentation at the 2023 ASCP

    24 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-announces-presentation-at-the-2023-american-society-of-clinical-psychopharmacology-ascp-annual-meeting-301832708.html

    PR NEWSWIRE
    24 May 2023
    Share Share
    Lighthouse Announces Progression of LHP588 Clinical Development Program
    Lighthouse Announces Progression of LHP588 Clinical Development Program

    10 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-announces-progression-of-lhp588-clinical-development-program-in-alzheimers-disease-301820267.html

    PR NEWSWIRE
    10 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search